Skip to main content

Table 2 Outcome of anti-reflux therapy over 3.3 ± 1.1 years with respect to esophagus and asthmatic symptoms

From: A preliminary investigation of anti-reflux intervention for gastroesophageal reflux related childhood-to-adult persistent asthma

Symptom Number of patents (percent) Symptom score Symptom score reduction rate,% P-value
   Pre-treatment Post-treatment   (2-tailed)
Regurgitation 50 (87.7%) 5.8 ± 2.0 1.2 ± 1.8 75.1 ± 35.9 <0.001
Heartburn 49 (86.0%) 5.6 ± 2.0 1.1 ± 1.6 75.3 ± 35.8 <0.001
Esophagus symptom 50 (87.7%) 11.3 ± 4.0 2.3 ± 3.2 75.5 ± 35.6 <0.001
Cough 46 (80.7%) 7.3 ± 1.6 2.8 ± 2.5 58.4 ± 34.9 <0.001
wheezing 57 (100%) 8.4 ± 1.2 3.8 ± 2.7 53.9 ± 32.4 <0.001
Chest tightness 55 (96.5%) 8.1 ± 1.5 3.9 ± 2.7 51.9 ± 32.7 <0.001
Asthmatic symptom 57 (100%) 22.1 ± 5.0 9.9 ± 7.2 54.3 ± 31.9 <0.001